Inactive Instrument
Company Bio Vitos Pharma
Stocks
BIOVIT
SE0023286919
Medical Equipment, Supplies & Distribution
Business description: Bio Vitos Pharma
Number of employees: 1
Sales by Activity: Bio Vitos Pharma
| Fiscal Period: December | 2020 (SEK) | 2021 (SEK) | 2022 (SEK) | 2023 (SEK) | 2024 (SEK) |
|---|---|---|---|---|---|
Diagnostic Kits / Equipment | 2.9M | 3.52M | 4.74M | 3M | 411K |
Geographical breakdown of sales: Bio Vitos Pharma
| Fiscal Period: December | 2020 (SEK) | 2021 (SEK) | 2022 (SEK) | 2023 (SEK) | 2024 (SEK) |
|---|---|---|---|---|---|
Sweden | 2.9M | 3.52M | 4.74M | 3M | 411K |
Executive Committee: Bio Vitos Pharma
| Manager | Title | Age | Since |
|---|---|---|---|
Sven Rohmann
CEO | Chief Executive Officer | 64 | 2024-12-31 |
Joen Averstad
CEO | Chief Executive Officer | 42 | 2019-05-14 |
| Chief Executive Officer | 49 | 2022-12-31 |
Composition of the Board of Directors: Bio Vitos Pharma
| Director | Title | Age | Since |
|---|---|---|---|
Richard Wall
CHM | Chairman | 63 | 2022-12-31 |
Bo Ziedén
BRD | Director/Board Member | 63 | 2022-12-31 |
Igor Lokot
BRD | Director/Board Member | 54 | 2022-12-31 |
Company details: Bio Vitos Pharma
Diagnostic & Testing Substances
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.89% | -2.05% | -22.39% | +3.85% | 177B | |
| -2.23% | +5.33% | -21.93% | +12.01% | 117B | |
| -1.69% | +0.02% | -3.01% | +27.96% | 116B | |
| +15.48% | +18.80% | -44.63% | +6.59% | 77.71B | |
| -0.83% | +3.13% | +3.98% | +80.36% | 65.51B | |
| +1.98% | +4.70% | +17.36% | +81.35% | 54.97B | |
| +0.28% | +3.72% | +1.75% | -24.86% | 52.79B | |
| -0.80% | +6.38% | -13.98% | +29.62% | 43.95B | |
| -6.39% | -5.64% | +17.29% | -6.64% | 32.35B | |
| Average | +0.63% | +3.37% | -7.29% | +23.36% | 81.91B | |
| Weighted average by Cap. | +0.75% | +3.03% | -12.34% | +20.82% |
